This site is intended for Healthcare professionals only.

Granules Hyderabad plant successfully closes USFDA inspection


Granules Hyderabad plant successfully closes USFDA inspection

New Delhi : Pharma firm Granules India said its Gagillapur facility in Hyderabad has completed USFDA inspection without any observations.

“The company’s Gagillapur facility located in Hyderabad, Telangana has successfully completed US FDA inspection without any observations,” Granules India said in a BSE filing.

“This facility manufactures finished dosages (FDs) and pharmaceutical formulation intermediates (PFIs).”

The stock of Granules India was trading 2.29 per cent higher at Rs 122.75 on BSE.



Source: self
0 comment(s) on Granules Hyderabad plant successfully closes USFDA inspection

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted